LeadIQ logo
Learn more at LeadIQ.com
Ultimovacs ASA logo

Ultimovacs ASA Employee Directory

Biotechnology ResearchOslo, Norway0-1 Employees

Ultimovacs is a biotechnology company focused on developing novel cancer immunotherapies. Its lead candidate UV1 is a peptide-based vaccine designed to elicit a targeted T cell response against telomerase, a broadly expressed cancer antigen. UV1 is being explored as a therapeutic cancer vaccine intended for use in combination with other immuno-oncology drugs, with a broad clinical program spanning Europe, Australia, and the USA.

Founded in 2011, the company traces its research origins to Oslo University Hospital and is headquartered in Oslo, with an additional office in Uppsala, Sweden, and it is publicly listed on Euronext Oslo. In recent developments, there have been reports of strategic activity involving Zelluna Immunotherapy and a planned business combination.

Find Ultimovacs ASA employees' phone numbers or email addresses

Ultimovacs ASA Global Highlights

Location
Employees

Europe
5

Minus sign iconPlus sign icon
  • Norway
    5

Asia
1

Minus sign iconPlus sign icon
  • Indonesia
    1

Ultimovacs ASA's Leadership

  • Cso at Ultimovacs ASA
    G. G.
    Cso
    Mobile Phone
  • Chief Financial Officer at Ultimovacs ASA
    H. V.
    Chief Financial Officer
    Mobile Phone
  • Employee at Ultimovacs ASA
    M. W.
    Mobile Phone

Ultimovacs ASA Employee Metrics

100%
50%
0%
2026
2025
  • Administrative
  • Biotechnology
  • Business
  • Other

Contact profiles from Ultimovacs ASA

Name
Title
Contact
Location
Last Update
  • Cso at Ultimovacs ASA
    G. G.
    Cso
    Mobile Phone
    Norway, Oslo
    Sep 06, 2026
  • Chief Financial Officer at Ultimovacs ASA
    H. V.
    Chief Financial Officer
    Mobile Phone
    Mar 10, 2026
  • Employee at Ultimovacs ASA
    M. W.
    Mobile Phone
    Sep 07, 2026

Frequently Asked Questions

What is Ultimovacs ASA known for?

Minus sign iconPlus sign iconUltimovacs ASA was founded in 2011 and operates in the Biotechnology Research industry. You can contact Ultimovacs ASA's main corporate office by phone at
+47-450-22****
. Explore Ultimovacs ASA's company overview page for more information.

What is Ultimovacs ASA's most common email format?

Minus sign iconPlus sign iconUltimovacs ASA employees' email format typically follows the pattern of First.Last@ultimovacs.com. Trying to find reliable and up-to-date employee contact data? Find more Ultimovacs ASA email formats with LeadIQ.

How many employees does Ultimovacs ASA have currently?

Minus sign iconPlus sign iconUltimovacs ASA has approximately 1 employees as of August 2026. These team members are located across 2 continents, including Europe and Asia.

Who are Ultimovacs ASA's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Ultimovacs ASA's key employees include:

  • Cso: G. G.
  • Chief Financial Officer: H. V.
  • : M. W.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

  • B2B data verified in real-time
  • Sync data to your CRM, & add it to an outreach sequence in one click
  • Integrations with your tech stack for optimal efficiency
  • A patented AI cold email generator
  • Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.